Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-12

Study Completion Date

2024-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess the efficacy of the SpyGlass DS for the detection of residual pancreatic calculations after endoscopic treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SpyGlass™ Discover Percutaneous

NCT04580940

Pancreatic Diseases Bile Duct Obstruction Bile Duct Diseases

COMPLETED

Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS

NCT02524418

Biliary Tract Disease

COMPLETED NA

Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis

NCT04131010

Pancreatitis, Calcific Pancreatitis, Chronic

UNKNOWN NA

SpyGlass Surgical Study

NCT05822635

Pancreatic Diseases Bile Duct Diseases Hepatic Disease

COMPLETED

Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)

NCT01556555

Sclerosing Cholangitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatitis, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SpyGlass DS after endoscopic treatment

Group Type EXPERIMENTAL

SpyGlass DS

Intervention Type DEVICE

Detection by the SpyGlass DS of residual pancreatic stones not detected by the standard method (CT scan and ERCP)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SpyGlass DS

Detection by the SpyGlass DS of residual pancreatic stones not detected by the standard method (CT scan and ERCP)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18 and over;
* with chronic calcifying pancreatitis;
* having already received endoscopic treatment for pancreatic pain related to stenosis and / or pancreatic stones;
* having given free, informed and written consent;
* being affiliated to a social security scheme or beneficiary of such a scheme.

Exclusion Criteria

* contraindications to performing an upper digestive endoscopy;
* haemorrhagic disease, haemostasis and coagulation disorder (PR \<60%, PTT\> 40 s and platelets \<60,000 / mm3;
* pregnant or breastfeeding woman;
* adult patient protected (guardianship or curatorship), or deprived of liberty by a judicial or administrative decision;
* person subject to a safeguard measure.

Minimum Eligible Age

18 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No